(Q34264297)

1 August 2017

title

Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B. (English)

1 reference

1 August 2017

main subject

anti-retroviral agent

0 references

1 reference

6

Bill G Kapogiannis

1 reference

1 August 2017

10

Grace M Aldrovandi

1 reference

1 August 2017

Kathleen Mulligan

1

1 reference

1 August 2017

D Robert Harris

2

1 reference

1 August 2017

Patricia Emmanuel

3

1 reference

1 August 2017

Roger A Fielding

4

1 reference

1 August 2017

Carol Worrell

5

1 reference

1 August 2017

Dina Monte

7

1 reference

1 August 2017

John Sleasman

8

1 reference

1 August 2017

Craig M Wilson

9

1 reference

1 August 2017

ATN 021 Protocol team

11

1 reference

1 August 2017

language of work or name

English

0 references

publication date

9 May 2012

1 reference

Clinical Infectious Diseases

1 August 2017

published in

1 reference

1 August 2017

volume

55

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

461-468

1 reference

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

The multiple faces of autoimmune-mediated bone loss

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Bone disease in HIV infection: a practical review and recommendations for HIV care providers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Prospective study of bone mineral density changes in aging men with or at risk for HIV infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Antiretroviral therapy and bone mineral measurements in HIV-infected youths.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Continuous antiretroviral therapy decreases bone mineral density

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

6 July 2018

Adolescent bone health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Vitamin D status in adolescents and young adults with HIV infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

A 12-month treatment with tenofovir does not impair bone mineral accrual in HIV-infected children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Z score prediction model for assessment of bone mineral content in pediatric diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491777

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

6 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Reduced bone mineral density in HIV-infected patients: prevalence and associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Bone mineral content is lower in prepubertal HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Assessment of bone acquisition in childhood and adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS455

Stable bone density in HAART-treated individuals with HIV: a meta-analysis

21 January 2018

1 reference

12 December 2020

High prevalence of reduced bone mineral density in primary HIV-1-infected men

1 reference

12 December 2020

The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1-infected patients

1 reference

12 December 2020

Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy

1 reference

12 December 2020

Bone Quality in Perinatally HIV-Infected Children: Role of Age, Sex, Growth, HIV Infection, and Antiretroviral Therapy

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIS455

1 reference

1 August 2017

1 reference

1 August 2017

1 reference